Paul M. Silva, SVP & Interim CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,930 shares at $179.35 ($889K) on 2019-02-11, disclosed to the SEC on 2019-02-13.
Seasonal sale ($889k) by SVP & Interim CFO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.35 | 1,400 | $251K | 28.2% |
| 2 | $180.38 | 2,100 | $379K | 42.6% |
| 3 | $181.09 | 715 | $129K | 14.6% |
| 4 | $181.09 | 715 | $129K | 14.6% |
| Total | $180.29 avg | 4,930 | $889K | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |